Vaxart (NASDAQ: VXRT) reported Q1 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $20.88 million versus the consensus estimate of $12.4 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.